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S U M M A R Y
Background: An altered microRNA proﬁle exists in many infectious diseases, including sepsis. CD39+
regulatory T-cells (Tregs) have a remarkable immunosuppressive effect and play an important role in the
regulation of immune balance in sepsis. However, the correlation between microRNA changes and the
ratio of CD39+ Tregs in sepsis patients has not yet been reported. The altered microRNA expression
proﬁle in sepsis patients was analyzed in this study. Moreover, the correlation between microRNAs and
disease severity and prognosis was investigated. Furthermore, the correlation between microRNAs and
the percentage of peripheral blood CD39+ Tregs was investigated and further veriﬁed in an animal model.
Methods: Sixty sepsis patients and 30 healthy controls were included. The difference in microRNA
expression was investigated by microRNA microarray and was further conﬁrmed by real-time
quantitative PCR. The correlations between microRNA changes and the Sepsis-related Organ Failure
Assessment (SOFA) score, severity of sepsis, and survival were analyzed. The percentage CD39+ Tregs in
the peripheral blood of sepsis patients was measured by ﬂow cytometry. The correlation between
microRNAs and the percentage CD39+ Tregs was analyzed and further conﬁrmed in a mouse sepsis
model.
Results: Compared to healthy controls, sepsis patients exhibited a signiﬁcantly elevated microRNA-155
(miR-155) level (p < 0.05), which was positively related to a higher SOFA score (r = 0.641, p < 0.05) and a
greater severity of sepsis. The area under the receiver operating characteristic curve of miR-155 used for
the prediction of 28-day survival was 0.763, with a cut-off point of 2.47. Patients with a miR-155 level
>2.47 had a lower 28-day survival (p < 0.05). The miR-155 level of patients was proportional to the
percentage of CD39+ Tregs (r = 0.637, p < 0.05). After transfection with miR-155 inhibitor, the ratio of
CD39+ Tregs in mice with sepsis was signiﬁcantly reduced (p < 0.05).
Conclusions: A higher level of miR-155 indicated a more severe condition and poorer prognosis in sepsis
patients. The possible underlying mechanism could be that miR-155 induces an increased percentage of
CD39+ Tregs and thus immunosuppression.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Sepsis is a systemic inﬂammatory response mainly due to
infection, which may result in multiple organ dysfunction
syndromes with a high mortality rate.1,2 Although progress has
been made in the prevention and control of sepsis in the last* Corresponding authors.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).decade, sepsis remains the main cause of death in intensive care
unit (ICU) patients.3 Early diagnosis and assessment are essential
for the prognosis of sepsis patients. Therefore, the development of
a biomarker for early diagnosis and accurate prognostic assess-
ment is warranted.4
MicroRNAs (miRNAs), small non-coding RNA with a length of
only 21–25 nucleotides, are expressed widely in eukaryotic cells,
functioning as post-translational regulators.5 miRNAs are stable in
blood, and thus with the advancements made in detection
technology, they represent promising biomarkers.6 Recent studies
have reported altered miRNA expression proﬁles in severalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Primers for real-time quantitative PCR
microRNA Forward primer sequence
hsa-miR-155 CCCCTATCACGATTAGCATTAA
hsa-miR-181b TTGTAAGTAACGACAGCCACCC
has-miR-27a UUCACAGUGGCUAAGUUCCGC
cfa-miR-155 GCCCGCTTAATGCTAATTGTGAT
cel-miR-39 GGAGGTTAATGCTAATTGTGATAG
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miRNA expression has become a recent focus of research. Moore
et al. found that the miR-222 level was elevated during septic
shock,7 while Wang et al. found that the miR-223 level was down-
regulated in the hearts of severely septic mice.8 In the present
study, with the use of a miRNA microarray assay and real-time
quantitative PCR (qRT-PCR), it was found that miR-155 was
overexpressed. Past studies have shown that miR-155 exerts a
regulatory effect on the proliferation and development of
regulatory T-cells (Tregs). Tregs have a strong immunosuppressive
function, and thus play an important role in maintaining immune
balance.9,10
The present study aimed to explore the relationship between
miR-155, Tregs, and the prognosis of sepsis patients. As an
important cell type in maintaining self-tolerance and regulating
the immune response in sepsis, CD4+CD25+ Tregs have gained
much attention in recent studies. Among the cell types, CD39+
Tregs possess a stronger immunosuppressive ability.11 Therefore,
this study focused on CD39+ Tregs. Previous studies have shown
that sepsis patients have an increased ratio of CD39+ Tregs, and the
percentage CD39+ Tregs has been correlated with the prognosis of
patients to some extent.12 However, whether the percentage of
CD39+ Tregs in sepsis patients is regulated by certain miRNAs
remains unclear. Therefore, the correlation between miRNA levels
and the percentage CD39+ Tregs in sepsis patients was investigated
and this was further conﬁrmed in animal experiments.
2. Materials and methods
2.1. Patients and samples
Sixty sepsis patients admitted to the Zhejiang Provincial
People’s Hospital during the period May 2012 to January 2014 were
included in this study; 30 healthy people served as healthy
controls. The diagnosis of sepsis was based on the deﬁnition of the
American College of Chest Physicians and Society of Critical Care
Medicine (ACCP/SCCM). The 60 sepsis patients were further
divided into three subgroups, namely the sepsis subgroup, severe
sepsis subgroup, and septic shock subgroup. According to the
criteria of the 2001 SCCM/ESICM/ACCP/ATS/SIS International
Sepsis Deﬁnition Conference, sepsis complicated with organ
dysfunction is referred to as ‘severe sepsis’, while sepsis
complicated with hypotension refractory to adequate volume
resuscitation in the absence of an alternate cause is termed ‘septic
shock’.
The exclusion criteria for this study were (1) age <18 years, (2)
HIV-infected patients, (3) patients with malignant tumors, (4)
patients taking immunosuppressive drugs, and (5) pregnant
patients. After admission to the ICU, the patient’s age, sex, and
Sepsis-related Organ Failure Assessment (SOFA) score were
recorded, along with other clinical information. Routine monitor-
ing of vital signs, testing of breathing and blood gas parameters,
and bacterial cultures were performed. Blood samples were
collected from the sepsis patients within 24 h of admission, while
blood samples were collected from healthy controls at the time of a
physical examination. Informed consent was obtained from all
patients. The study protocol was approved by the Ethics
Committee of Zhejiang Provincial People’s Hospital.
2.2. miRNA microarray analysis
The microRNAs in blood samples were extracted with the
MiRcute miRNA Extraction–Separation Kit (Beijing Tiangen
Biotech Co., Ltd).13 The microRNA chips were purchased from
Danish Exiqon. MicroRNA data were provided by the Sanger
miRBase Release Database (http://microrna.sanger.ac.uk/sequences/). MicroRNAs were ﬂuorescently labeled using T4
RNA ligase, and the labeled microRNAs were hybridized with
microarray chips for 12 h. miR-423-5p was used as a reference for
internal control. After hybridization, the chip scanning was
performed using the Luxscan10K/A scanning system (Capitalbio
Co., Ltd). Signiﬁcance Analysis of Microarrays 2.0 software was
used to compare the difference in microRNA expression between
healthy controls and sepsis patients.
2.3. Real-time quantitative PCR (qRT-PCR)
MicroRNA expression was further conﬁrmed by qRT-PCR
according to the microRNA microarray results. The extraction
procedure was the same as that described above. Reverse
transcription of microRNA to cDNA was performed using the
One Step PrimeScript miRNA cDNA Synthesis Kit (Dalian Takara
Co., Ltd) following the manufacturer’s instructions. The cDNA
obtained was further ampliﬁed by qRT-PCR using SYBR Premix Ex
Taq II (Dalian Takara Co., Ltd) with speciﬁc primers (Table 1). The
relative fold changes in microRNAs were calculated by 2DDCt
method (normalized by cel-miR-39); DCt = Ct(target)  Ct(cel-
miR-39), DDCt = [Ct(target)  Ct(cel-miR-39)]patients  [Ct(target)
 Ct(cel-miR-39)]healthy controls.
2.4. Analysis of the correlation between the miR-155 level and sepsis
severity and the prognosis of sepsis patients
The correlation between the miR-155 level and SOFA score of
60 sepsis patients was determined, and the differences in miR-155
levels among the sepsis, severe sepsis, and septic shock subgroups
were analyzed. The 28-day survival of patients after admission was
recorded and the miR-155 levels were compared between patients
who died and those who survived. The clinical accuracy of miR-155
for 28-day survival was analyzed by receiver operating character-
istic (ROC) curve. All 60 patients were divided into a high miR-155
level group and a low miR-155 level group according to the cut-off
of the ROC curve. The Kaplan–Meier survival curve was plotted to
compare the difference in 28-day survival.
2.5. Analysis of the CD39+ Treg percentage in sepsis patients
The blood samples of sepsis patients and healthy controls were
centrifuged at 800 rpm for 5 min and the supernatant was
removed. Erythrocyte lysate was then added and the tubes
allowed to stand for 5 min; these were further centrifuged at
800 rpm for 5 min. After discarding the supernatant, the cells were
washed twice with phosphate buffered saline (PBS) and resus-
pended with a cell density adjusted to 1  106/ml. The antibodies
anti-CD4-FITC, anti-CD25-PE, anti-CD127-PerCP, and anti-CD39-
APC (BD Pharmingen Corporation) were added and the tubes
incubated at 4 8C in darkness for 15 min. Analysis of the CD39+ Treg
percentage was performed using the BD FACSCalibur system with
FlowJo software. Tregs were deﬁned as CD4+CD25+CD127
lymphocytes. The percentage of CD39+ Tregs = (CD39+ Treg
count/total count of Treg cells)  100%.
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miR-155 inhibitor
The construction of the mouse sepsis model was performed as
described by Mutlak et al., with minor modiﬁcations.14 In brief,
cecum ligation and dissection was performed on 6-month-old male
C57BL/6 mice to induce sepsis. Mice in the sham group received a
laparotomy only. All operations were handled by a single person to
avoid bias. Moreover, a similar ligation site was chosen to ensure
uniformity of the sepsis model. Successful modeling was considered
in the presence of clinical symptoms including malaise, fever, chills,
piloerection, generalized weakness, and reduced gross motor
activity. The miR-155 level was compared between the sham group
and the sepsis group. Furthermore, another batch of mice with sepsis
were transfected with miR-155 inhibitor and microRNA inhibitor
negative control using Entranster-in vivo transfection reagent
(Engreen Biosystem Co., Ltd). The transfection was performed
according to the manufacturer’s protocol. Forty-eight hours after
transfection, blood samples were collected from the tail vein and the
percentage CD39+ Tregs was analyzed by ﬂow cytometry. The
research was conducted in accordance with the Guide for Care and
Use of Laboratory Animals as adopted and promulgated by the
United National Institutes of Health. All experimental protocols were
approved by the Review Committee for the Use of Human or Animal
Subjects of Zhejiang Provincial People’s Hospital.
2.7. Statistical analysis
The statistical analysis was performed using SPSS v. 17.0 soft-
ware (SPSS Inc., Chicago, IL, USA). Data with a non-normal
distribution were expressed as the median and those with a
normal distribution as the mean  standard deviation. For the non-
normal data, the Mann–Whitney test was performed to compare two
groups. For normal data, one-way analysis of variance (ANOVA) was
performed to compare multiple groups, followed by the least
signiﬁcant difference (LSD) test. The difference in frequency
distribution between groups was determined by Chi-square test.
Spearman correlation analysis was performed. The 28-day survival
was calculated by Kaplan–Meier curves with the log-rank test. The
criterion for signiﬁcance was set as p < 0.05.Table 2
Demographic characteristics of the study patients
Healthy controls
(n = 30)
Sepsis patients (n =
Sepsis subgroup
(n = 14)
Age, years, median (range) 42 (23–55) 45.5 (19–62) 
Sex
Male 20 8 
Female 22 6 
Blood culture
Negative NA 3 
Bacterial, Gram-positive NA 3 
Bacterial, Gram-negative NA 7 
Fungi NA 1 
Primary infection site
Respiratory tract NA 4 
Urinary tract NA 3 
Abdomen NA 7 
SOFA score NA 5.5 (3–8) 
C-reactive protein, mg/l NA 51.5 (11–118) 
Procalcitonin, mg/l NA 4.5 (2.3–7.0) 
ICU stay, days, median (range) NA 13 (7–16) 
28-day survival NA
Yes NA 10 
No NA 4 
NA, not applicable; SOFA, Sepsis-related Organ Failure Assessment; ICU, intensive care3. Results
3.1. MicroRNA microarray and qRT-PCR
The basic characteristics of the 60 sepsis patients and
30 healthy controls are shown in Table 2. As shown in Figure 1a,
a total 11 microRNA changes were observed in sepsis patients
compared to healthy controls (fold-changes more than 1.5;
p < 0.05). Based on the results of the microRNA microarray
analysis, the three microRNAs with the most signiﬁcant changes
were selected (fold of increase or decrease) and qRT-PCR
conﬁrmation was performed. qRT-PCR showed that, compared
with the healthy controls, only the expression of miR-155
was signiﬁcantly increased in sepsis patients (p < 0.05)
(Figure 1b–d).
3.2. Correlation between miR-155 levels and sepsis severity and the
prognosis of sepsis patients
Correlation analysis showed that the miR-155 level in sepsis
patients was proportional to the SOFA score (r = 0.641, p < 0.05)
(Figure 2a). Among the 60 sepsis patients, 28 had severe sepsis and
18 had septic shock. There was no statistically signiﬁcant
difference in age, sex, or infection site between the three subgroups
(sepsis, severe sepsis, and septic shock) (p > 0.05). Patients in the
septic shock subgroup had the highest miR-155 level, and the miR-
155 level in the severe sepsis subgroup was signiﬁcantly higher
than that in the sepsis subgroup (p < 0.05) (Figure 2b). Thirty-ﬁve
patients were alive at 28 days after admission. The miR-155 level of
the surviving patients was signiﬁcantly lower than that of the
patients who died (p < 0.05, Figure 2c).
As shown in Figure 3a, the area under the ROC curve (AUC) of
miR-155 used for the prediction of 28-day mortality in sepsis
patients was 0.763 (95% conﬁdence interval 0.626–0.901, p < 0.05)
and the cut-off point was 2.47. The Kaplan–Meier survival analysis
showed that patients with a miR-155 level >2.47 had a lower 28-
day survival rate (27.7% vs. 71.4%, p < 0.05) (Figure 3b). Overall,
these results suggest that a higher miR-155 level could be a risk
factor for sepsis patients. The miR-155 level can also be used to
predict the prognosis of patients. 60) p-Value
Severe sepsis subgroup
(n = 28)
Septic shock subgroup
(n = 18)
48 (26–65) 46 (22–69) 0.831
11 10 0.629
17 8
5 3 0.422
7 2
15 11
1 2
12 8 0.866
6 4
10 6
8 (6–10) 10 (9–11) <0.0001
67.5 (24–132) 81 (40–162) <0.0001
5.2 (3.1–7.5) 5.6 (4.2–8.0) <0.0001
17 (12–19) 22.5 (16–25) 0.006
19 6 0.036
9 12
 unit.
Figure 1. MicroRNA changes in blood samples collected from sepsis patients within 24 h after admission to the ICU. (a) Microarray analysis showing 11 changed microRNAs in
the sepsis patients. (b)–(d) Three signiﬁcantly changed microRNAs were conﬁrmed by qRT-PCR. The relative expression of miR-155 was signiﬁcantly higher in sepsis patients,
while the relative expressions of miR-27a and miR-181b were not.
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Tregs
Flow cytometry analysis showed that the percentage of CD39+
Tregs in sepsis patients was signiﬁcantly higher than that in the
healthy controls (p < 0.05) (Figure 4a). Further subgroup analysisFigure 2. An increased miR-155 level is associated with the severity of sepsis. (a) The miR
the highest miR-155 level compared to the other subgroups. (c) The miR-155 level is prevealed that the percentage of CD39+ Tregs in the septic shock
subgroup was the highest, and the percentage in the severe sepsis
subgroup was higher than that in the sepsis subgroup (p < 0.05).
Correlation analysis showed that the miR-155 level of sepsis
patients was positively correlated with the percentage of CD39+
Tregs (r = 0.637, p < 0.05, Figure 4b).-155 level is positively correlated with the SOFA score. (b) Septic shock patients have
ositively correlated with the mortality of sepsis patients.
Figure 3. The miR-155 level could be used as a prognostic marker for sepsis patients. (a) Receiver operating characteristic (ROC) curve of miR-155 used for the prediction of
28-day mortality. (b) Kaplan–Meier survival curve showing a lower 28-day survival rate in patients with a higher miR-155 level.
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septic mice
The miR-155 level in the group of septic mice was signiﬁcantly
higher than that of the sham group mice (p < 0.05, Figure 5a). The
percentage of CD39+ Tregs in septic mice was also higher than that
of the shams (p < 0.05). Compared to the septic mice without miR-
155 inhibitor transfection, the septic mice transfected with miR-
155 inhibitor in vivo had a lower percentage of CD39+ Tregs
(p < 0.05, Figure 5b). These results indicate that miR-155 plays a
role in inducing CD39+ Tregs in sepsis.
4. Discussion
Several biomarkers, such as C-reactive protein and procalcito-
nin, have been used clinically for the early diagnosis of sepsis.
However, these biomarkers have some limitations in terms of
speciﬁcity and sensitivity.4,15 Thus, it is necessary to develop otherFigure 4. The percentage change in CD39+ Tregs in sepsis patients. (a) An increased percen
positively correlated with the percentage CD39+ Tregs.biomarkers for use in the diagnosis and assessment of sepsis.
MicroRNAs are stable in blood and relatively easy to detect
quantitatively. Therefore, a number of studies have focused on the
clinical value of microRNAs as potential biomarkers, especially in
infectious diseases.16,17 In the present study, through microRNA
microarray and qRT-PCR analysis, it was found that the miR-155
levels of sepsis patients were signiﬁcantly elevated compared to
those of healthy controls. Moreover, the miR-155 level was
positively correlated with the severity of the sepsis and the
prognosis of the patients. In brief, patients with septic shock had
the highest level of miR-155, and the miR-155 level of patients
with severe sepsis was higher than that of sepsis patients. The level
of miR-155 of patients who died within 28 days in the ICU was
signiﬁcantly higher than that of surviving patients. Patients with a
high expression of miR-155 had a low 28-day survival rate. In
addition, ROC curve analysis showed that the prediction of 28-day
mortality of sepsis patients using miR-155 had a satisfactory
clinical efﬁcacy.tage of CD39+ Tregs is associated with the severity of sepsis. (b) The miR-155 level is
Figure 5. The miR-155 level in mice with sepsis and its relationship with the percentage CD39+ Tregs. (a) The miR-155 level in mice with sepsis is signiﬁcantly higher. (b) miR-
155 inhibitor decreases the percentage of CD39+ Tregs in mice with sepsis; *p < 0.05 compared with sham mice, #p < 0.05 compared with miR-155 inhibitor transfected
septic mice.
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in the regulation of various proinﬂammatory genes and are
associated with proliferation, differentiation, and apoptosis of a
variety of inﬂammatory cells in sepsis, and thus correlated with the
prognosis.17–19 Since the immune imbalance that leads to an
uncontrolled inﬂammatory response is the central process of
sepsis, the present study focused on the regulatory effect of
microRNAs on immune balance in sepsis patients.20 Meanwhile,
dysregulation of microRNA expression might also lead to abnormal
immune regulation in sepsis patients.17 Anti-inﬂammatory regi-
mens have recently been applied in the treatment of sepsis
patients, however the therapeutic effect has been unsatisfacto-
ry.21,22 Bone proposed the hypothesis of a ‘compensatory anti-
inﬂammatory response syndrome’ (CARS), which suggests that the
key to sepsis occurrence lies in an immune imbalance.23 Excessive
anti-inﬂammation would lead to secondary immunosuppression,
which may account for the development of a secondary infection or
uncontrolled inﬂammation in sepsis patients.24,25 Therefore, the
prevention or reversal of immunosuppression is an important part
of the treatment of sepsis.26 CD4+CD25+ Tregs could maintain
immune tolerance with their immunosuppressive function. The
percentage of CD4+CD25+ Tregs can reﬂect the state of immune
suppression.27,28 An elevated percentage of CD4+CD25+ Tregs can
be detected in diseases with excessive immunosuppression, such
as sepsis.29 More importantly, CD39+ Tregs possess a much
stronger immunosuppressive ability. In this study, the percentage
of CD39+ Tregs in sepsis patients was higher than that of the
healthy controls and increased with the severity of disease, which
is consistent with previous ﬁndings.12 It was also found that the
level of miR-155 was positively related to the percentage of CD39+
Tregs in sepsis patients. In order to further conﬁrm this result, a
mouse model of sepsis was constructed and it was found that the
percentage of CD39+ Tregs in mice transfected with miR-155
inhibitor was lower. This indicates that miR-155 may induce
CD39+ Tregs in sepsis.
miR-155, a B-cell receptor-induced gene product, exists in
activated B-cells and T-cells and regulates the functions of Th1 and
Th2 cells by promoting the differentiation of Th cells to Th2
cells.30,31 Apart from this, miR-155 is closely correlated with theproliferation of Tregs. A previous study has shown that a high
expression of miR-155 exists in Tregs.32 For example, miR-155
deﬁcient rats have a Treg proliferation disorder.33 Therefore, it
was speculated that a high miR-155 level may enhance the
proliferation of CD39+ Tregs, thus causing immunosuppression
and further aggravating the disease or inducing a poor prognosis
in sepsis patients. The frequency and expression levels of CD39
correlate with those of Foxp3 in CD4+ T-cells,34 which indicates
that a higher Foxp3 could lead to an elevated CD39 expression.
Moreover, miR-155 could induce Foxp3 mRNA expression. This
might be the possible underlying mechanism for the positive
correlation between miR-155 and the percentage CD39+ Tregs.
Studies have also shown that the expression levels of CD39
correlate with the frequency and expression levels of CD25
receptor and CD73.35 However, data to support the idea that miR-
155 might inﬂuence the expression of CD25 receptor and CD73
are lacking. Further studies focusing on the underlying mecha-
nisms are warranted.
There are some limitations of the current study. The sample
sizes are relatively small and only observational results are
presented. Moreover, due to low transfection efﬁciency, an in vitro
experiment to clarify the underlying mechanisms between miR-
155 and CD39+ Tregs was not performed.
In conclusion, the results of this study suggest that for sepsis
patients, a higher level of miR-155 can be an indicator of a severe
condition and a poor prognosis. The potential mechanism is
probably that miR-155 enhances the percentage of CD39+ Tregs
and thus induces immunosuppression.
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